Effects of lipoic acid, caffeic acid and a synthesized lipoyl-caffeic conjugate on human hepatoma cell lines

Article abstract of DOI:10.3390/molecules16086365

Hepatocellular carcinoma (HCC) is among the most aggressive and fatal cancers. Its treatment with conventional chemotherapeutic agents is inefficient, due to several side effects linked to impaired organ function typical of liver diseases. Consequently, there exists a decisive requirement to explore possible alternative chemopreventive and therapeutic strategies. The use of dietary antioxidants and micronutrients has been proposed for HCC successful management. The aim of this work was to test in vitro the effects of lipoic acid, caffeic acid and a new synthesized lipoylcaffeic conjugate on human hepatoma cell lines in order to assess their effect on tumor cell growth. The results of cytotoxicity assays at different times showed that the cell viability was directly proportional to the molecule concentrations and incubation times. Moreover, to evaluate the pro- or anti-inflammatory effects of these molecules, the cytokine concentrations were evaluated in treated and untreated cellular supernatants. The obtained cytokine pattern showed that, at the increasing of three molecules concentrations, three pro-inflammatory cytokines such as IL-1α, IL-8 and TNF-α decreased whereas the antiinflammatory cytokine such as IL-10 increased.

Full text of DOI:10.3390/molecules16086365

Molecules 2011, 16, 6365-6377; doi:10.3390/molecules16086365
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
Effects of Lipoic Acid, Caffeic Acid and a Synthesized
Lipoyl-Caffeic Conjugate on Human Hepatoma Cell Lines
1
,†
1,†
1
1,
Eliana Guerriero , Angela Sorice , Francesca Capone , Susan Costantini *,
2
3
1
Pasquale Palladino , Marco D'ischia and Giuseppe Castello
1
“
“
Pascale Foundation” National Cancer Institute - Cancer Research Center, Mercogliano (AV) Italy
Pascale Foundation” National Cancer Institute, Naples, Italy
2
3
Department of Organic Chemistry and Biochemistry, University of Naples Federico II, Naples, Italy
†
These authors have contributed equally to this work.
*
Author to whom correspondence should be addressed; E-Mail: susan.costantini@unina2.it;
Tel.: +39-08251911752; Fax: +39-08251911705.
Received: 10 June 2011; in revised form: 22 July 2011 / Accepted: 26 July 2011 /
Published: 27 July 2011
Abstract: Hepatocellular carcinoma (HCC) is among the most aggressive and fatal
cancers. Its treatment with conventional chemotherapeutic agents is inefficient, due to
several side effects linked to impaired organ function typical of liver diseases.
Consequently, there exists a decisive requirement to explore possible alternative
chemopreventive and therapeutic strategies. The use of dietary antioxidants and
micronutrients has been proposed for HCC successful management. The aim of this work
was to test in vitro the effects of lipoic acid, caffeic acid and a new synthesized lipoyl-
caffeic conjugate on human hepatoma cell lines in order to assess their effect on tumor cell
growth. The results of cytotoxicity assays at different times showed that the cell viability
was directly proportional to the molecule concentrations and incubation times. Moreover,
to evaluate the pro- or anti-inflammatory effects of these molecules, the cytokine
concentrations were evaluated in treated and untreated cellular supernatants. The obtained
cytokine pattern showed that, at the increasing of three molecules concentrations, three
pro-inflammatory cytokines such as IL-1β, IL-8 and TNF-α decreased whereas the anti-
inflammatory cytokine such as IL-10 increased.
Keywords: antioxidants; lipoic acid; caffeic acid; cytokines

Molecules 2011, 16
. Introduction
6366
1
HCC is the sixth most common type of cancer in the World, with rates increasing from year to year
and its incidence is mainly correlated with chronic hepatitis B and C virus infection and liver cirrhosis
1-4]. HCC treatment with conventional chemotherapeutic agents is inefficient, due to several side
[
effects linked to impaired organ function typical of liver disease; in fact these therapies offer a
probability of 5-year survival of 50–70% [5]. Therefore, the limited effectiveness of chemotherapy and
high recurrence rate highlights the urgent need to identify new molecular targets and to develop new
treatments. Numerous epidemiological studies have recently highlighted the existence of an inverse
association between fruits and vegetables consumption, natural antioxidants and cancer risk; in fact,
the antioxidants intake through diet or supplements of plant origin is strongly recommended for cancer
prevention and cure [6]. In general, the antioxidants are substances of vegetable or mineral or animal
origin that neutralize free radicals and protect the body from their negative actions on the plasma
membrane, proteins and DNA [7-9]. In particular, they can prevent cancer by interfering with its early
processes and, at the same time, stimulating the immune system to destroy cancer cells and to block
their proliferation. Some studies on mouse models have shown that antioxidants are able to promote
regression of several types of cancer [10]. In this work we have studies the effects of natural
antioxidants on human hepatoma cell lines and focused the attention on lipoic and caffeic acid because
both are present in many animal species and vegetables. Lipoic acid was first isolated in 1951 from
bovine liver extracts [11] and exists in an open (DHLA) or close (LA) state in which two sulfhydryl
groups, in position 6 and 8, are interconvertible by redox reactions [12,13]. It is a cofactor of several
enzymes involved in the conversion process of glucose, and fatty acids into ATP, and, thus, is involved
in the Krebs cycle. Caffeic acid (3,4-dihydroxycinnamic acid) is so-named because it was originally
found in the coffee extracts [14]. Its antioxidant power depends by redox reactions of two hydroxyl
groups of phenolic ring. The beneficial antioxidant properties of caffeic acid have been demonstrated
both in vivo and in vitro [15]. Since the use of dietary antioxidants has been proposed as effective
against some cancers and, also, HCC, we have synthesized a new antioxidant molecule, namely
2
-S-lipoyl-caffeic acid, by condensation of sulfur atom of reduced form of lipoic acid (DHLA) with
phenolic ring of caffeic acid, in order to try to improve the antioxidant activity of two natural
molecules, and to reduce the proliferation of hepatoma cells.
2
. Results and Discussion
2.1. 2-S-lipoyl-caffeic acid synthesis
Lipoic acid was reduced to dihydrolipoic acid with sodium borohydride (NaBH ) for 10 minutes at
4
room temperature in doubly distilled water deoxygenated by purging with argon gas. Residual NaBH
4
was eliminated by acidification with HCl solution [16]. Caffeic acid (3,4-dihydroxycinnamic acid) was
oxidized to its ortho-quinone form in CH CN at room temperature, purged with argon gas, with
3
polymer-supported periodate in three minutes [17]. Subsequently, the periodate resin was quickly
filtered off and the caffeic acid ortho-quinone solution was added to dihydrolipoic acid solution.
The formation of 2-S-lipoyl-caffeic acid was monitored by UV-visible spectroscopy and liquid
chromatography-mass spectrometry (LC-ESI-MS) [18]. Figure 1 shows the UV-VIS spectrum of

Molecules 2011, 16
6367
2
-S-lipoyl-caffeic acid taken at HPLC peak apex at retention time (RT) 6.58 minutes, showing three
maxima at 222, 253 and 323 nm recognized as characteristic of 2-S-thionyl-caffeic acid adduct [19].
LC-ESI-MS analysis of reaction product at retention time (RT) 6.58 minutes reported in Figure 1
showed two predominant experimental peaks with m/z values equal to 385.2 and 779.4, confidently
assigned to 2-S-lipoyl caffeic acid mass and double mass, respectively, although slightly different from
the theoretical molecular weight 386.09. However these differences between the experimental and
theoretical masses are due to small calibration error of LC-ESI-MS instrument.
Figure 1. Far-UV spectrum and spectrum ESI.
2
.2. Colorimetric assay with Sulforhodamine B
The cell viability was determined after 24, 48 and 72 h stimulation by three antioxidants in HepG2
and Huh7 to identify the IC50 concentration, corresponding to the chemical concentration that causes
5
0% inhibition of cell growth (Figure 2). The cellular viability of untreated cells was used as control.
2
.3. Cytotoxicity assay on HepG2 cells
HepG2 cells showed a good level of viability after 24 and 48 h treatment with different
concentrations of lipoic acid, caffeic acid and 2-S-lipoyl-caffeic acid; in fact, there was a reduction in
cell viability but not significant, as evidenced by the overlapping of growth curves in Figure 2. The
decrease in cell viability became significant after 72 h incubation concerning 0.5 mM concentration for
both caffeic acid and 2-S-lipoyl-caffeic acid and 0.8 mM for lipoic acid (Figure 2; Table 1S in
Supplementary Material). However, caffeic acid after 72 h was more effective than lipoic acid,
whereas it showed similar efficacy respect to 2-S-lipoyl-caffeic acid.

Molecules 2011, 16
Figure 2. HepG2 and Huh7 cell lines growth curves in the absence and presence of lipoic
6368
acid, caffeic acid and 2-S-lipoyl-caffeic acid. On the x-axis is showed the different
molecular concentrations (mM), on the y-axis cell growth rate (CR).
2
.4. Cytotoxicity assay on Huh7 cells
After 24 h treatment with all three antioxidants the cytotoxicity assay on Huh7 cell line showed no
significant inhibitory effects on cell proliferation, while after 48 h treatment with 0.8 mM caffeic acid

Molecules 2011, 16
6369
and 1 mM 2-S-lipoyl-caffeic acid it caused an significant inhibition of tumor cellular growth (Table 2S
in Supplementary Material). The IC50 corresponding to cell viability reduction equal to 50–80%
compared to control cells was obtained after 72 h incubation with lipoic acid, caffeic acid and
2
-S-lipoyl-caffeic acid using the 0.75, 0.2 and 0.3 mM doses, respectively (Figure 2). Therefore,
caffeic acid, as for HepG2, showed a greater cytotoxic effect than lipoic acid.
2.5. Bio-Plex assay
We evaluated the cytokines production in HepG2 cellular supernatants after incubation with three
molecules at 72 h and in Huh7 after incubation at 48 and 72 h by Bio-Plex assay. The results obtained
were compared with untreated cells used as control. These experiments showed that the levels of three
pro-inflammatory cytokines, like TNF-α, IL-8 and IL-1β, decreased in statistically significant way at
concentration increasing of caffeic acid, lipoic acid and 2-S-lipoyl-caffeic acid. However, this decrease
was dependent dose in both HepG2 and Huh7 treated at 72 h, whereas in Huh7 treated at 48 h a
significant reduction was observed only using 0.5 mM caffeic acid and 1 mM 2-S-lipoyl-caffeic acid in
agreement with the results of cytotoxicity test (Figures 3–5). Moreover, IL-10 being anti-inflammatory
cytokine showed a statistically significant increase in Huh7 cells treated at 48 h using 0.5 mM caffeic
acid and 1 mM 2-S-lipoyl-caffeic acid, and in HepG2 and Huh7 treated at 72 h using increasing dose
of all three antioxidants (Figures 3–5).
Figure 3. Cytokines levels in HepG2 cell line after 72 h of treatment.

Molecules 2011, 16
Figure 4. Cytokines levels in Huh7 cell line after 48 h of treatment.
6370
Figure 5. Cytokines levels in Huh7 cell line after 72 h of treatment.
2
.6. Discussion
The use of antioxidants may be useful tool to contrast or at least to balance the tumor growth, so
they could represent an effective resource in anticancer therapeutic strategies. Two natural antioxidants
molecules (i.e., lipoic acid, and caffeic acid), tested in this work, highlighted good potential as
inhibitors of tumor cell growth in vitro with dose and time dependent toxic effect. This was in
agreement to previous papers that showed a significant decrease in cell proliferation of HepG2 cells

Molecules 2011, 16
6371
after 72 h of incubation with lipoic acid using the 100–500 μM concentrations [20] and the reduction
in cell viability of HepG2 after stimulation with 200 μg/mL caffeic acid for 24 h [21].
Moreover, the caffeic acid role in anticancer prevention strategies has been recently investigated in
Huh7 cells that, treated with CADPE, a caffeic acid derivate, showed an inhibition of the expression
levels of cyclin D1, an important regulator of cell cycle that promotes the proliferation and tumor
growth [22,23].
Our data also evidenced that Huh7 cells were more sensitive to antioxidants than HepG2 cells,
reaching IC after 48 h of treatment. These results could depend from the fact that Huh7 cells are
5
0
more undifferentiated respect to HepG2. In fact, recent studies have shown that the Huh7 cell line is
associated with low expression of cytokeratin 8/18 (CK8/18), while HepG2 cell line is correlated with
high expression of CK8/18 being usually expressed in normal hepatocytes [24]. In addition, HepG2
cells express p53 in their native form while Huh7 cells constitutively express the mutated form of the
same protein and, therefore, are characterized by a more malignant phenotype [25].
To try to enhance the positive effects of these antioxidants we have synthesized a new conjugated
molecule, namely 2-S-lipoyl-caffeic acid, that resulted to have a cytotoxicity level similar to caffeic
acid, and this could be due to the presence in the newly synthesized molecule of three hydroxyl groups
present in caffeic acid.
Since in HCC the inflammation persistence resulted to play an important role in the transition from
a chronic liver disease to neoplastic process [26,27] we also studied the immunomodulatory role of
these three antioxidants on the production of cytokines in hepatoma cellular supernatants by a
multiplex biometric ELISA-based immunoassay. In literature it is reported that HepG2 cells expressed
mRNAs of various cytokines including IL-8, IL-10 and TNF-α [28,29]. On the other hand, studies on
HCC patients, conducted in our laboratory, showed that high levels of IL-8 correlated with tumor size
suggesting that this interleukin could have a role in the HCC progression and could be considered a
marker of tumor invasiveness [26]. Our results showed that lipoic acid, caffeic acid and
2-S-lipoyl-caffeic acid induced the decreasing of pro-inflammatory cytokines such as TNF-α, IL-1β
and IL-8 and the increasing of anti-inflammatory cytokines such as IL-10. This suggested that these
three molecules can promote tumor regression and inhibit tumor invasiveness. In particular, TNF-α
is a pro-inflammatory cytokine that plays an important role in apoptosis, proliferation, in cell
differentiation and viral replication and the increase of its expression is involved in many diseases and
cancers [30]. Its high levels are known to induce in HCC the activation of anti-apoptotic transcription
factor NF-kB, that promotes cell survival and tumor progression [31,32]. Therefore, a reduction of
TNF-α, as found in this study, could indicate that it anticipates the activation of NF-kB by blocking
tumor growth. This agreed to other papers reporting that lipoic acid and caffeic acid inhibited in a
dose-dependent way the activation of NF-kB induced by TNF-α, both in human U937 histocyte cells
and in human aortic endothelial cells [33,34] and that caffeic acid can reduced the TNF-α expression in
gastric epithelial cells stimulated with Helicobacter pylori [35], in RAW264,7 cells [36] and
endothelial cells of the middle ear HMEECs [37].
Moreover, IL-8 is a pro-inflammatory chemokine having a strong pro-angiogenic activity in HCC
patients [38] and its expression in HepG2 cells has been correlated with invasiveness and tumor
metastasis because it increased more in the later stages of HCC [39]. IL-8 reduction obtained after the
treatment of HepG2 and Huh7 cells with lipoic acid, caffeic acid and 2-S-lipoyl-caffeic acid, suggested

Molecules 2011, 16
6372
that it could inhibit the tumor invasiveness promoting cellular regression in according to some studies
on caffeic acid that evidenced that this molecule reduced its expression in endothelial cells HUVEC
[40], in Caco-2 cells [41], and in SW620 colon epithelial cells [42].
On the other hand IL-1β promotes inflammatory processes by stimulating the production of
prostaglandins and other cytokines and its reduction, obtained in our work, was consistent with a
published work which showed significant reduction of IL-1β in HepG2 and Huh7 treated with
2
5 μg/mL of caffeic acid (CAPE) [43].
Finally, IL-10 has a direct effect on apoptosis by blocking the activation of NF-kB, and its increase
could lead to programmed cell death of tumor cells as already demonstrated in a study conducted on
primary cultures of rat hepatocytes and HepG2 cell line [44] and in another studies on HCC patients in
the later stages of disease [45,46].
3. Experimental
3.1. General
Lipoic and caffeic acid were purchased from VWR International (Leuven, Belgium), HPLC
chemicals were purchased from Lab-Scan (Dublin, Ireland), other chemicals were purchased from
Sigma Aldrich (St. Louis, MO, USA) and the columns for purification and characterization were
purchased from Phenomenex (Torrance, CA, USA). Product purity and integrity was confirmed by
LC–ESI-MS (Finnigan Surveyor, Thermo Electron Corporation) applying a linear gradient of
acetonitrile/0.05% TFA in water/0.05% TFA from 40 to 95% over 13 min.
3
.2. Cell culture
Human hepatoma cell lines (HepG2, Huh7) were kept in culture and expanded at 37 °C in a
humidified atmosphere of 5% CO2 in culture medium DMEM (Dulbecco's Modified Eagle's Medium,
Lonza, Verviers, Belgium), supplemented with FBS (Invitrogen, Camarillo, CA, USA) at 10%,
Penicillin/Streptomycin 100× (Euroclone, Devon, UK), Glutamax 100× (Invitrogen) and non-essential
2+
2+
amino acids 100× (Invitrogen). Phosphate buffer (PBS phosphate buffered saline Ca and Mg free)
2
+
2+
and trypsin (Ca and Mg free) were supplied by Euroclone.
3
.3. Colorimetric assay with Sulforhodamine B
Cell proliferation was assessed in presence and absence of lipoic acid, caffeic acid and 2-S-lipoyl-
caffeic acid by colorimetric assay with sulforhodamine B (SRB, Sigma Aldrich) [47]. The cells
4
(
2 × 10 ) were seeded in 96-multiwell plates in 200 μL of culture medium, and left to grow for 24 h at
37 °C for allowing adhesion. Then, the cells were treated with these molecules using different
concentrations (0.01 mM, 0.05 mM, 0.1 mM, 0.2 mM, 0.5 mM and 1 mM) and incubated for 24, 48
and 72 h. All the antioxidants were dissolved in dimethyl sulfoxide (DMSO, Sigma Aldrich) at a
concentration of 100 mM. In cell cultures the DMSO concentration remained always below 0.1%, a
dose that did not exert toxic effects [48]. Then, the cells were fixed for 1h at 4 °C with 50%
trichloroacetic acid (TCA, Sigma Aldrich). Subsequently, the cells were washed with distilled water

Molecules 2011, 16
6373
and were dried to air. 100 µL of SRB was added to each well and the plate was incubated for 30 min at
RT. To remove the dye excess the cells were washed using 1% acetic acid. The number of viable cells
was directly proportional to the protein bound-dye formation which was then solubilized with 10 mM
Tris base solution pH 10.5 and measured by fluorometric assay ELISA at 540 nm (Bio-Rad, Hercules,
CA, USA; Microplate Reader). All experiments were performed in duplicate and were repeated for
three times. The cellular viability was estimated as % compared to untreated cells.
3.4. Bio-Plex assay
A multiplex biometric ELISA-based immunoassay, containing dyed microspheres conjugated with
a monoclonal antibody specific for a target protein was used, according to the manufacturer’s
instructions (Bio-Plex, Bio-Rad), to evaluate the trends and the concentrations of different cytokines
after 24, 48 and 72 h of incubation with the molecules in the cellular supernatants. Soluble molecules
were measured using an Ultrasensitive Human Cytokine 10-Plex Panel (Invitrogen, Corporation, 542
Flynn Rd, Camarillo, CA). In particular, the following cytokines were evaluated: GM-CSF, IL-1β,
IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IFNγ and TNF-α. Each experiment was performed in duplicate as
previously described [26,27]. Protein concentrations were determined using a Bio-Plex array reader
(
Luminex, Austin, TX) and the analyte concentration was calculated using a standard curve, with
software provided by the manufacturer (Bio-Plex Manager Software).
3
.5. Statistical analysis
The cytokines concentrations evaluated in treated vs. untreated cell lines were compared by T-test.
Values of p < 0.05 were considered to be statistically significant. The statistical program Prism 4
GraphPad Software, San Diego, CA, USA) was used.
(
4
. Conclusions
HCC treatment with conventional chemotherapeutic agents is inefficient, due to several side effects
linked to impaired organ function typical of liver diseases. Therefore, it needs to explore possible
alternative chemopreventive and therapeutic strategies. In fact, the use of dietary antioxidants and
micronutrients has been recently proposed for HCC successful management [7-9]. For these reasons, in
this work we have synthesized lipoyl-caffeic conjugate and tested in vitro the effects of lipoic acid,
caffeic acid and new molecule on human hepatoma cell lines. Moreover, we have evaluated the
cytokine concentrations in treated and untreated cellular supernatants in order to evaluate the pro- or
anti-inflammatory effects of three molecules. In conclusion our data evidenced that (a) these
antioxidants inhibited the tumor cell growth in dose and time dependent way, (b) they induced the
TNF-α, IL-1β and IL-8 decrease and the IL-10 increase promoting tumor regression and (c) new
molecule 2-S-lipoyl-caffeic acid had a cytotoxic effects similar to caffeic acid. Therefore, further
studies will regard the design and the synthesis of new molecules containing a different number of
hydroxyl groups respect to caffeic acid, and blocking the second SH group present in lipoic acid.

Molecules 2011, 16
6374
Conflict of Interest
The authors declare no conflict of interest.
References
1
2
3
4
. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin.
2
005, 55, 74-108.
. Bosch, F.X.; Ribes, J.; Diaz, M.; Cleries, R. Primary liver cancer: worldwild incidence and trends.
Gastroenterology 2004, 127, 5-16.
. Edmondson, H.A.; Henderson, B.; Benton, B. Liver-cell adenomas associated with use of oral
contraceptives. N. Engl. J. Med. 1976, 294, 470-472.
. McGlynn, K.A.; London, W.T. Epidemiology and natural history of hepatocellular carcinoma.
Best Pract. Res. Clin. Gastroenterol. 2005, 19, 3-23.
5
6
. Bruix, J.; Sherman, M. Diagnosis of small HCC. Gastroenterology 2005, 129, 1364.
. Stanner, S.A.; Hughes, J.; Kelly, C.N.; Buttriss, J. A review of the epidemiological evidence for
the 'antioxidant hypothesis'. Public Health Nutr. 2004, 7, 407-422.
7
8
9
1
1
1
. Halliwell, B. Free radicals and antioxidants -quo vadis? Trends Pharmacol. Sci. 2011, 32,
1
25-130.
. Harman, D. Free-radical theory of aging. Increasing the functional life span. Ann. N.Y. Acad. Sci.
994, 717, 1-15.
1
. Simonian, N.A.; Coyle, J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev.
Pharmacol .Toxicol. 1996, 36, 83-106.
0. Stoner, G.D.; Mukhtar, H. Polyphenols as cancer chemopreventive agents. J. Cell. Biochem.
Suppl. 1995, 22, 169-180.
1. Reed, L.J.; DeBusk, B.G.; Gunsalus, I.C.; Hornberger, C.S., Jr. Crystalline α-lipoic acid: A
catalitic agent associated with pyruvate dehydrogenase. Science 1951, 114, 93-94.
2. Packer, L.; Witt, E.H.; Tritschler, H.J. alpha-Lipoic acid as a biological antioxidant. Free Radic.
Biol. Med. 1995, 19, 227-250.
1
3. Bast, A.; Haenen, G.R. Lipoic acid: a multifunctional antioxidant. Biofactors 2003, 17, 207-13.
4. Farah, A.; Monteiro, M.; Donangelo, C.M.; Lafay, S. Chlorogenic acids from green coffee extract
are highly bioavailable in humans. J. Nutr. 2008, 138, 2309-2315.
1
1
5. Sato, Y.; Itagaki, S.; Kurokawa, T.; Ogura, J.; Kobayashi, M.; Hirano, T.; Sugawara, M.; Iseki, K.
In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int. J. Pharm.
2
011, 17, 403:136-403:138.
6. Gailit, J. Restoring free sulfhydryl groups in synthetic peptides. Anal. Biochem. 1993, 214,
34-335.
1
1
1
3
7. Fulcrand, H.; Cheminat, A.; Brouillard, R.; Cheynier, V. Characterization of compounds obtained
by chemical oxidation of caffeic acid in acidic condition. Phytochemistry 1994, 35, 499-505.
8. Bassil, D.; Makris, D.P.; Kefalas, P. Oxidation of caffeic acid in the presence of L-cysteine:
isolation of 2-S-cysteinylcaffeic acid and evaluation of its antioxidant properties. Food Res. Int.
2
005, 38, 395-402.

Molecules 2011, 16
6375
1
2
9. Cilliers, J.J.L.; Singleton, V.L. Caffeic acid Autoxidation and the effects of Thiols. J. Agric. Food
Chem. 1990, 38, 1789-1796.
0. Simbula, G.; Columbano, A.; Ledda-Columbano, G.M.; Sanna, L.; Deidda, M.; Diana, A.;
Pibiri, M. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of
hepatoma cells. Apoptosis 2007, 12, 113-123.
2
1. Chung, T.W.; Moon, S.K.; Chang, Y.C.; Ko, J.H.; Lee, Y.C.; Cho, G.; Kim, S.H.; Kim, J.G.;
Kim, C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on
hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual
mechanism. FASEB J. 2004, 18, 1670-1681.
2
2
2
2
2
2
2
2. Won, C.; Lee, C.S.; Lee, J.K.; Kim, T.J.; Lee, K.H.; Yang, Y.M.; Kim, Y.N.; Ye, S.K.;
Chung, M.H. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking
IL-6-induced STAT3 activation. Anticancer Res. 2010, 30, 481-488.
3. Parekh, P.; Rao, K.V. Overexpression of cyclin D1 is associated with elevated levels of MAP
kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis. Cell.
Biol. Int. 2007, 31, 35-43.
4. Jabari, S.; Meissnitzer, M.; Quint, K.; Gahr, S.; Wissniowski, T.; Hahn, E.G.; Neureiter, D.;
Ocker, M. Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells
in vitro and in vivo. Int. J. Oncol. 2009, 35, 69-80.
5. Hussain, S.P.; Schwank, J.; Staib, F.; Wang, X.W.; Harris, C.C. TP53 mutations and
hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene
2
007, 26, 2166-2176.
6. Capone, F.; Costantini, S.; Guerriero, E.; Calemma, R.; Napolitano, M.; Scala, S.; Izzo, F.;
Castello, G. Serum cytokine levels in patients with hepatocellular carcinoma. Eur. Cytokine Netw.
2
010, 21, 99-104.
7. Costantini, S.; Capone, F.; Guerriero, E.; Maio, P.; Colonna, G.; Castello, G. Serum cytokine
levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.
Eur. Cytokine Netw. 2010, 21, 251-256.
8. Stonāns, I.; Stonāne, E.; Russwurm, S.; Deigner, H.P.; Böhm, K.J.; Wiederhold, M.; Jäger, L.;
Reinhart, K. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine 1999, 11,
1
51-156.
2
3
3
9. Shin, E.C.; Choi, Y.H.; Kim, J.S.; Kim, S.J.; Park, J.H. Expression patterns of cytokines and
chemokines genes in human hepatoma cells. Yonsei Med. J. 2002, 43, 657-664.
0. Liu, Z.G.; Han, J. Cellular responses to tumor necrosis factor. Curr. Issues Mol. Biol. 2001, 3,
7
9-90.
1. Ataseven, H.; Bahcecioglu, I.H.; Kuzu, N.; Yalniz, M.; Celebi, S.; Erensoy, A.; Ustundag, B. The
levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due
to HBV and HDV infection. Mediators Inflamm. 2006, 2006, 78380.
3
3
2. Fabregat, I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J. Gastroenterol.
2
009, 15, 513-520.
3. Natarajan, K.; Singh, S.; Burke, T.R., Jr.; Grunberger, D.; Aggarwal, B.B. Caffeic acid phenethyl
ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
Proc. Natl. Acad. Sci. USA 1996, 93, 9090-9095.

Molecules 2011, 16
6376
3
3
4. Zhang, W.J.; Frei, B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and
adhesion molecule expression in human aortic endothelial cells. FASEB J. 2001, 15, 2423-2432.
5. Abdel-Latif, M.M.; Windle, H.J.; Homasany, B.S.; Sabra, K.; Kelleher, D. Caffeic acid phenethyl
ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1
expression in gastric epithelial cells. Br. J. Pharmacol. 2005, 146, 1139-1147.
3
6. Jung, W.K.; Choi, I.; Lee, D.Y.; Yea, S.S.; Choi, Y.H.; Kim, M.M.; Park, S.G.; Seo, S.K.;
Lee, S.W.; Lee, C.M.; et al. Caffeic acid phenethyl ester protects mice from lethal endotoxin
shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide
synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways. Int.
J. Biochem. Cell. Biol. 2008, 40, 2572-2582.
3
7. Song, J.J.; Cho, J.G.; Hwang, S.J.; Cho, C.G.; Park, S.W.; Chae, S.W. Inhibitory effect of caffeic
acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells.
Acta Otolaryngol. 2008, 128, 1303-1307.
3
8. Akiba, J.; Yano, H.; Ogasawara, S.; Higaki, K.; Kojiro, M. Expression and function of interleukin-
8
in human hepatocellular carcinoma. Int. J. Oncol. 2001, 18, 257-264.
3
9. Kubo, F.; Ueno, S.; Hiwatashi, K.; Sakoda, M.; Kawaida, K.; Nuruki, K.; Aikou, T. Interleukin 8
in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with
tumor angiogenesis. Ann. Surg. Oncol. 2005, 12, 800-807.
4
4
4
4
4
4
4
4
0. Moon, M.K.; Lee, Y.J.; Kim, J.S.; Kang, D.G.; Lee, H.S. Effect of caffeic acid on tumor necrosis
factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol.
Pharm. Bull. 2009, 32, 1371-1377.
1. Zhao, Z.; Shin, H.S.; Satsu, H.; Totsuka, M.; Shimizu, M. 5-caffeoylquinic acid and caffeic acid
down-regulate the oxidative stress- and TNF-alpha-induced secretion of interleukin-8 from Caco-
2
cells. J. Agric. Food Chem. 2008, 56, 3863-3868.
2. Fitzpatrick, L.R.; Wang, J.; Le, T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-
kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J. Pharmacol.
Exp. Ther. 2001, 299, 915-920.
3. Zhang, T.; Guo, C.J.; Li, Y.; Douglas, S.D.; Qi, X.X.; Song, L.; Ho, W.Z. Interleukin-1beta
induces macrophage inflammatory protein-1beta expression in human hepatocytes. Cell. Immunol.
2
003, 226, 45-53.
4. Santiago-Lomelí, M.; Gómez-Quiroz, L.E.; Ortíz-Ortega, V.M.; Kershenobich, D.;
Gutiérrez-Ruiz, M.C. Differential effect of interleukin-10 on hepatocyte apoptosis. Life Sci. 2005,
7
6, 2569-2579.
5. Hsia, C.Y.; Huo, T.I.; Chiang, S.Y.; Lu, M.F.; Sun, C.L.; Wu, J.C.; Lee, P.C.; Chi, C.W.;
Lui, W.Y.; Lee, S.D. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth
factor as tumor markers for hepatocellular carcinoma. Eur. J. Surg. Oncol. 2007, 33, 208-212.
6. Delhem, N.; Cottrez, F.; Carpentier, A.; Miroux, C.; Moralès, O.; François, V.; Groux, H.;
Auriault, C.; Pancré, V. Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression.
Bull. Cancer 2008, 95, 1029-1038.
7. Bruzzese, F.; Di Gennaro, E.; Avallone, A.; Pepe, S.; Arra, C.; Caraglia, M.; Tagliaferri, P.;
Budillon, A. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase

Molecules 2011, 16
6377
inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo. Clin. Cancer
Res. 2006, 12, 617-625.
4
8. Tirosh, O.; Sen, C.K.; Roy, S.; Kobayashi, M.S.; Packer, L. Neuroprotective effects of alpha-
lipoic acid and its positively charged amide analogue. Free Radic. Biol. Med. 1999, 26,
1
418-1426.
©
2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
http://creativecommons.org/licenses/by/3.0/).
(